# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 2566 results.
Risk of Ovarian Cancer in Patients With a Pelvic Mass
Status: Completed
Last Changed: Nov 08, 2011
First Received: Apr 19, 2006
Disease(s): Ovarian Cancer
Intervention(s): Biomarker Assay (CA125 and HE4)
Locations: Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
Richard Moore, Providence, Rhode Island, United States
EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Status: Active, not recruiting
Last Changed: Jan 07, 2019
First Received: Dec 04, 2013
Disease(s): Ovarian Cancer
Intervention(s): Paclitaxel + Carboplatin every 3 weeks, Carboplatin monotherapy every 3 weeks, Weekly Paclitaxel and Carboplatin
Locations: Notre-Dame Hospital of the CHUM, Montréal, Canada
Herlev Hospital, Herlev, Denmark
Kuopio University Hospital, Kuopio, Finland
Service d'Oncologie Médicale - Centre Hospitalier d'Alès, Alès, France
Service d'Oncologie Médicale - ICO Paul Papin, Angers, France
... and 59 other locations.
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Status: Completed
Last Changed: Feb 25, 2015
First Received: Aug 31, 2004
Disease(s): Ovarian Cancer
Intervention(s): Docetaxel, Carboplatin
Locations: Florida Gynecologic Oncology, Fort Myers, Florida, United States
Jupiter Medical Center-Gynecology Oncology and Gynecology, Jupiter, Florida, United States
Florida Hospital/Gyn/Onc Department, Orlando, Florida, United States
Hematology-Onc. Assoc. of The Quad Cities, Bettendorf, Iowa, United States
University of Iowa, Iowa City, Iowa, United States
... and 15 other locations.
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Platinum-resistant Ovarian Cancer (PROC) (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
Status: Recruiting
Last Changed: Feb 19, 2020
First Received: May 07, 2019
Disease(s): Ovarian Cancer
Intervention(s): NovoTTF-100L(O), Paclitaxel
Locations: Maryland Oncology Hematology, P.A., Silver Spring, Maryland, United States
Minnesota Oncology Hematology, PA - US Oncology, Woodbury, Minnesota, United States
Northwest Cancer Specialists, PC - US Oncology, Portland, Oregon, United States
Texas Oncology - San Antonio - US Oncology, San Antonio, Texas, United States
KH der Barmherzigen Brüder Graz, Graz, Austria
... and 31 other locations.
Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer
Status: Completed
Last Changed: Feb 18, 2015
First Received: Mar 21, 2013
Disease(s): Recurrent Epithelial Ovarian Cancer
Intervention(s): Catumaxomab
Locations: Charité Campus Virchow-Klinikum, Berlin, Germany
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
Status: Terminated
Last Changed: Nov 24, 2011
First Received: Jan 05, 2007
Disease(s): Ovarian Cancer
Intervention(s): Abagovomab, Placebo
Locations: Cedars-Sinai Medical Center, Los Angeles, California, United States
University of California, Los Angeles (UCLA), Los Angeles, California, United States
Stanford University, Stanford, California, United States
University of Colorado, Denver, Colorado, United States
University of Connecticut Health Center, Farmington, Connecticut, United States
... and 146 other locations.
China Ovarian Cancer BRCA Testing Study
Status: Recruiting
Last Changed: Feb 18, 2020
First Received: Jun 29, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, BeiJing, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Guangzhou, China
... and 10 other locations.
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer
Status: Withdrawn
Last Changed: Nov 02, 2016
First Received: Feb 12, 2009
Disease(s): Ovarian Cancer
Intervention(s): Azacitidine, Azacitidine, Azacitidine
Locations: Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center, Maywood, Illinois, United States
Central Dupage Hospital, Winfield, Illinois, United States
Open Label Immunotherapy Trial for Ovarian Cancer
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Jun 14, 2018
Disease(s): Ovarian Cancer
Intervention(s): Tableted vaccine (V3-OVA) containing ovarian cancer antigens
Locations: Immunitor LLC, Ulaanbaatar, Mongolia
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
Status: Recruiting
Last Changed: May 22, 2018
First Received: Jan 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): MRI
Locations: NKI-AVL, Amsterdam, Netherlands